Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Daly

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Diabetes, Obesity & Metabolism|May 23, 2025
Beyond diabetes: Testing long-term metformin adherence for dementia preventionTimothy Daly, Simon Okholm, Bruno P Imbimbo
Neuroscience|March 24, 2025
Letters to the editor generated by AI in neuroscience: The role of neuroethicsJaime A Teixeira da Silva, Timothy Daly
Annals of Biomedical Engineering|March 22, 2026
Linguistic, Orthographic, and Typographical Errors in Science (LOTS): A Growing Threat to Academic IntegrityJaime A Teixeira da Silva, Timothy Daly
Clinical Orthopaedics and Related Research|June 4, 2026
Reply to the Letter to the Editor: Editorial: AI-assisted Letters to the Editor-Scope of a Growing Ethical and Practical Concern, and CORR's Approach to Managing ItTimothy Daly, Jaime A Teixeira da Silva
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2024
Are lecanemab and donanemab disease-modifying therapies?Timothy Daly, Kasper P Kepp, Bruno P Imbimbo
Developing World Bioethics|March 14, 2023
Combining state-led distribution with a parallel market-based distribution to improve COVID-19 vaccine distributionManuel Zeledón-Ramírez, Timothy Daly, Luis García-Valiña
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Response to "Variability of cognitive changes after donanemab treatment"Timothy Daly, Kasper P Kepp, Bruno P Imbimbo
Theoretical Medicine and Bioethics|January 18, 2021
The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocolsTimothy Daly, Ignacio Mastroleo, David Gorski, et al.
Journal of Alzheimer'S Disease : JAD|January 10, 2022
An Argument for Simple Tests of Treatment of Alzheimer's DiseaseTimothy Daly, Ignacio Mastroleo, Vincent Henry, et al.
The Journal of Physiology|September 22, 2025
Physical activity and reduced risk of Alzheimer's disease: potential role of soluble amyloid-β42Timothy Daly, Alberto J Espay, Bruno P Imbimbo
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Diabetes, Obesity & Metabolism|May 23, 2025
Beyond diabetes: Testing long-term metformin adherence for dementia preventionTimothy Daly, Simon Okholm, Bruno P Imbimbo
Neuroscience|March 24, 2025
Letters to the editor generated by AI in neuroscience: The role of neuroethicsJaime A Teixeira da Silva, Timothy Daly
Annals of Biomedical Engineering|March 22, 2026
Linguistic, Orthographic, and Typographical Errors in Science (LOTS): A Growing Threat to Academic IntegrityJaime A Teixeira da Silva, Timothy Daly
Clinical Orthopaedics and Related Research|June 4, 2026
Reply to the Letter to the Editor: Editorial: AI-assisted Letters to the Editor-Scope of a Growing Ethical and Practical Concern, and CORR's Approach to Managing ItTimothy Daly, Jaime A Teixeira da Silva
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2024
Are lecanemab and donanemab disease-modifying therapies?Timothy Daly, Kasper P Kepp, Bruno P Imbimbo
Developing World Bioethics|March 14, 2023
Combining state-led distribution with a parallel market-based distribution to improve COVID-19 vaccine distributionManuel Zeledón-Ramírez, Timothy Daly, Luis García-Valiña
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Response to "Variability of cognitive changes after donanemab treatment"Timothy Daly, Kasper P Kepp, Bruno P Imbimbo
Theoretical Medicine and Bioethics|January 18, 2021
The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocolsTimothy Daly, Ignacio Mastroleo, David Gorski, et al.
Journal of Alzheimer'S Disease : JAD|January 10, 2022
An Argument for Simple Tests of Treatment of Alzheimer's DiseaseTimothy Daly, Ignacio Mastroleo, Vincent Henry, et al.
The Journal of Physiology|September 22, 2025
Physical activity and reduced risk of Alzheimer's disease: potential role of soluble amyloid-β42Timothy Daly, Alberto J Espay, Bruno P Imbimbo
Pageof 13